Co-promotion & Co-marketing – World Partnering Phrases & Agreements in Pharma, Biotech & Diagnostics, 2010 to 2018 (2019 Replace) –

Co-promotion & Co-marketing - Global Partnering Terms & Agreements in Pharma, Biotech & Diagnostics, 2010 to 2018 (2019 Update) -

Co-promotion and Co-marketing Partnering Phrases and Agreements in Pharma,
Biotech & Diagnostics 2010-2018”
report has been added to’s

The report offers complete understanding and unprecedented entry
to the co-promotion and co-marketing partnering agreements entered into
by the worlds main biopharma firms.

This report offers particulars of the newest co-promotion and co-marketing
agreements introduced within the pharmaceutical, biotechnology and diagnostic
sectors. Absolutely revised and up to date, the report covers particulars of
co-promotion and co-marketing agreements from 2010 to 2018.

For pharmaceutical and biotechnology professionals, the report provides
an in depth understanding and evaluation of how and why firms enter
co-promotion and co-marketing offers. The vast majority of offers are
multicomponent whereby the licensor retains both a proper or choice to
co-promote/market the resultant product of the analysis collaboration.
There are additionally quite a few pure co-promotion/advertising and marketing offers whereby the
merchandise originator takes on a co-promotion/advertising and marketing companion so as
to maximise a merchandise presence within the market.

Understanding the pliability of a potential companion’s negotiated
offers phrases offers vital perception into the negotiation course of in
phrases of what you may anticipate to attain through the negotiation of phrases.
While many smaller firms can be in search of particulars of the funds
clauses, the satan is within the element when it comes to how funds are
triggered – contract paperwork present this perception the place press releases
and databases don’t.

This report accommodates a complete itemizing of all co-promotion and
co-marketing offers introduced since 2010 as recorded within the Present
Agreements offers and alliances database, together with monetary phrases the place
obtainable, plus hyperlinks to on-line copies of precise co-promotion and
co-marketing contract paperwork as submitted to the Securities Trade
Fee by firms and their companions.

Contract paperwork present the solutions to quite a few questions on a
potential companion’s flexibility on a variety of vital points,
lots of which can have a big impression on every social gathering’s capability to
derive worth from the deal.

Matters Coated

Govt Abstract

Chapter 1 – Introduction

Chapter 2 – Traits in co-promotion and co-marketing

2.1. Introduction

2.2. Distinction between co-promotion and co-marketing offers

2.3. Traits in co-promotion offers since 2010

2.3.1. Co-promotion and co-marketing dealmaking by 12 months, 2010 to 2018

2.3.2. Co-promotion and co-marketing dealmaking by part of growth,
2010 to 2018

2.3.3. Co-promotion and co-marketing dealmaking by trade sector, 2010
to 2018

2.3.4. Co-promotion and co-marketing dealmaking by remedy space, 2010 to

2.3.5. Co-promotion and co-marketing dealmaking by expertise kind, 2010
to 2018

2.3.6. Co-promotion and co-marketing dealmaking by most lively firm,
2010 to 2018

2.4. When co-marketing will be helpful

2.5. When co-marketing is the one possibility

2.6. Pure offers and multi-component offers

2.6.1. Attributes of pure co-promotion offers

2.6.2. Attributes of co-promotion in multi-component offers

2.7. Causes for together with co-promotion choices in a deal

2.8. Uptake of co-promotion rights

2.9. Co-promotion rights as bargaining chips

2.10. Aligning companions to make the co-promote work

2.11. The way forward for co-promotion as a part of multicomponent offers

Chapter 3 – Overview of co-promotion deal construction

3.1. Introduction

3.2. Pure versus multi-component co-promotion offers

3.3. Pure co-promotion settlement construction

3.3.1. Instance co-promotion agreements

3.3.1.a. Case examine 1: Allergan – MAP Prescribed drugs

3.3.1.b. Case examine 2: Genzyme – Veracyte

3.4. Co-promotion rights as a part of a wider alliance settlement

3.4.1. Instance co-promotion possibility clauses

3.4.1.a. Case examine 3: Takeda Pharmaceutical- Orexigen Therapeutics

3.4.1.b. Case examine 4: Celgene – Acceleron Pharma

3.4.2. Instance co-promotion proper clauses

3.4.2.a. Case examine 5: Takeda – Orexigen

3.4.2.b. Case examine 6: Abbvie – Receptos

3.5. Embedded co-promotion rights enabling third social gathering engagement

3.5.1. Instance co-promotion clauses enabling third social gathering engagement

3.5.1.a. Case examine 7: Astellas – Ambit Biosciences

Chapter 4 – Overview of co-marketing deal construction

4.1. Introduction

4.2. Co-marketing settlement construction

4.2.1. Instance co-marketing agreements

4.2.1.a. Case examine 8: AstraZeneca -Ironwood Prescribed drugs

4.3. Co-marketing rights as a part of a wider alliance settlement

4.3.1. Instance co-marketing proper clauses

4.3.1.a. Case examine 9: Lundbeck – Myriad Genetics

Chapter 5 – Main co-promotion and co-marketing offers

5.1. Introduction

5.2. High co-promotion and co-marketing offers by worth

Chapter 6 – High 50 most lively co-promotion and
co-marketing dealmakers

6.1. Introduction

6.2. High 50 most lively co-promotion and co-marketing dealmakers

Chapter 7 – Co-promotion and co-marketing settlement
contracts listing 2010- 2018

7.1. Introduction

7.2. Co-promotion and co-marketing offers with contracts 2010 to 2018


Appendix 1 – Co-promotion and co-marketing offers by firm A-Z

Appendix 2 – Co-promotion and co-marketing offers by stage of growth

Appendix 3 – Co-promotion and co-marketing offers by deal kind

Appendix 4 – Co-promotion and co-marketing offers by remedy space

Appendix 5 – Co-promotion and co-marketing offers by expertise kind

Appendix 6 – Deal kind definitions

For extra details about this report go to

Supply hyperlink

This site uses Akismet to reduce spam. Learn how your comment data is processed.